Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06357377
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-10
First Post:
2024-03-13
Brief Title:
A Study of the Safety Dosing and Delivery of NEO100 in Patients with Pediatric Brain Tumors
Sponsor:
Neonc Technologies Inc
Organization:
Neonc Technologies Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| High Grade Glioma |
| Pediatric Tumor of CNS |
| Pediatric Tumor of Brain |
| Diffuse Midline Glioma H3 K27M-Mutant |
| Pediatric Tumor of Brain Stem |
| Pineocytoma |
| Choroid Plexus Carcinoma Childhood |
| Spinal Cord Tumor |
Keywords:
| Name | View |
|---|---|
| NEO100 | View |
| High grade glioma | View |
| Diffuse Midline Glioma | View |
| H3 K27-altered | View |
| Diffuse hemispheric glioma | View |
| H3 G34-mutant | View |
| Diffuse pediatric-type HGG | View |
| H3-wildtype | View |
| IDH-wildtype | View |
| spinal cord tumors | View |
| Brainstem | View |
| Posterior fossa | View |
| Choroid plexus carcinoma | View |
| CNS embryonal tumors | View |
| Pineoblastoma | View |